A passive cavitation detection setup is used to assess and verify the capability of frequency- and amplitudemodulated ultrasound burst signals on the generation of inertial cavitation. The measurements were conducted with a flowthrough tissue-mimicking phantom with a canal of dc = 1mm in diameter simulating a fine blood vessel. By means of a flow velocity of vf= 50mm/s circulating blood in the cardiovascular system is imitated. Applying signal frequencies from f = 550 − 950 kHz and peak rarefaction pressures in a range from ˆpPRFP ≈ 0.17 − 1.81 MPa, various ultrasound stimuli with alternating signal parameters were investigated in the absence and presence of a talcum-water mixture acting as cavitation nuclei. By evaluating the broadband emissions in the frequency domain and calculating the voltage spectral density Srm, the results can be compared. The findings of the present study demonstrate that each ultrasound stimulus triggers a similar strength of cavitation noise at the same Mechanical Index, representing a certain pressure. Over the whole frequency and Mechanical Index (pressure) range, each ultrasound signal type generates a voltage spectral density from Srm= 0.25 − 2.25 V/ √ Hz.
A promising approach to drug delivery applications for chemotherapeutics is the use of drug carriers to reduce the total amount of cytostatics, minimizing side effects. In addition, the carriers, loaded with the drug, can be guided to the tumorous tissue via the vascular system, which enables a local drug release (LDR). In our case, LDR is activated due to the sonosensitive behavior of the nanocapsules by inertial cavitation (IC) caused by focused ultrasound (FUS). Thereby, IC is excited by employing sound pressures within the recommended limit allowed for diagnostic ultrasound. In order to verify this drug delivery approach for its clinical suitability, a tissue-mimicking flow -through phantom, containing a small vessel, is used. Investigations have shown that the drug releasing cavitation effect associated with the sonosensitive and biocompatible nanocapsules also occurs in fine vessel structures, even in the case of moving particles and vessel diameters dc smaller than the wavelength λ.
Employing sonosensitive nanoparticles as carriers of active pharmaceutical ingredients emerges in ultrasonic Drug Delivery. Drug release can be initiated by focused ultrasound via the effect of inertial cavitation in certain target areas of particle loaded tissue. For stimulating inertial cavitation, a specific peak rarefaction pressure threshold must be exceeded. This pressure threshold has to be determined in order to estimate the risk of tissue damage during the drug release procedure. Therefore, this study provides a method to reliably verify the cavitation pressure threshold of sonosensitive and biocompatible nanoparticles.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.